Value of minimal residual disease in patients with early cancer of the tongueULANOVSKI, David; STERN, Yoram; ROIZMAN, Pepy et al.American journal of otolaryngology. 2004, Vol 25, Num 4, pp 240-244, issn 0196-0709, 5 p.Article

PRAME mRNA levels in cases with acute leukemia : Clinical importance and future prospectsPAYDAS, Semra; TANRIVERDI, Kahraman; YAVUZ, Sinan et al.American journal of hematology. 2005, Vol 79, Num 4, pp 257-261, issn 0361-8609, 5 p.Article

Reply to: What do we mean by sensitivity when we talk about detecting minimal residual disease? by Steinbach et alROSS, D. M; BRANFORD, S; MELO, J. V et al.Leukemia. 2009, Vol 23, Num 4, pp 819-820, issn 0887-6924, 2 p.Article

Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemiaMORTUZA, Forida Y; PAPAIOANNOU, Mary; MOREIRA, Ilidia M et al.Journal of clinical oncology. 2002, Vol 20, Num 4, pp 1094-1104, issn 0732-183XArticle

Enhanced sensitivity of flow cytometry for routine assessment of minimal residual diseaseDOMINGO, Esther; MORENO, Cristina; SANCHEZ-IBARROLA, Alfonso et al.Haematologica (Roma). 2010, Vol 95, Num 4, pp 691-692, issn 0390-6078, 2 p.Article

Can surgery for cancer accelerate the progression of secondary tumors within residual minimal disease at both local and systemic levels? DiscussionQADRI, Syed S. A; WANG, Jiang-Huai; COFFEY, J. C et al.The Annals of thoracic surgery. 2005, Vol 80, Num 3, pp 1046-1051, issn 0003-4975, 6 p.Conference Paper

Recent advances in the detection of bone marrow micrometastases : A promising area for research or just another false hope? A review of the literature : Bone metastasis and cancerATHANASSIADOU, Pauline; GRAPSA, Dimitra.Cancer metastasis reviews. 2006, Vol 25, Num 4, pp 507-519, issn 0167-7659, 13 p.Article

Monitoring of minimal residual disease in acute myeloid leukemia : Acute leukemiasKERN, Wolfgang; SCHOCH, Claudia; HAFERLACH, Torsten et al.Critical reviews in oncology/hematology. 2005, Vol 56, Num 2, pp 283-309, issn 1040-8428, 27 p.Article

MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemiaFELLER, N; VAN DER POL, M. A; VAN STIJN, A et al.Leukemia. 2004, Vol 18, Num 8, pp 1380-1390, issn 0887-6924, 11 p.Article

The expression of PRAME in chronic lymphoproliferative disordersPROTO-SIQUEIRA, Rodrigo; PASSETTO FALCAO, Roberto; DE SOUZA, Carmino Antonio et al.Leukemia research. 2003, Vol 27, Num 5, pp 393-396, issn 0145-2126, 4 p.Article

Insufficient ability of omental milky spots to prevent peritoneal tumor outgrowth supports omentectomy in minimal residual diseaseOOSTERLING, S. J; VAN DER BIJ, G. J; BÖGELS, M et al.Cancer immunology and immunotherapy. 2006, Vol 55, Num 9, pp 1043-1051, issn 0340-7004, 9 p.Article

Determination of minimal residual disease in leukaemia patientsCAMPANA, Dario.British journal of haematology. 2003, Vol 121, Num 6, pp 823-838, issn 0007-1048, 16 p.Article

Modelling a minimal residual disease-based treatment strategy in childhood acute lymphoblastic leukaemiaCAMPBELL, Peter J; MORLEY, Alexander A.British journal of haematology. 2003, Vol 122, Num 1, pp 30-38, issn 0007-1048, 9 p.Article

Risk classification at the time of diagnosis differentially affects the level of residual disease in children with B-precursor acute lymphoblastic leukemia after completion of therapyOKCU, M. Fatih; ROBERTS, W. Mark; JOHNSTON, Dennis A et al.Leukemia research. 2003, Vol 27, Num 8, pp 743-750, issn 0145-2126, 8 p.Article

Risk-adapted treatment according to minimal residual disease in adult ALLGÖKBUGET, Nicola; KNEBA, Michael; RAFF, Thorsten et al.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 4, pp 639-652, issn 1521-6926, 14 p.Article

Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detectionGAIPA, G; BASSO, G; COLIVA, T et al.Leukemia. 2005, Vol 19, Num 1, pp 49-56, issn 0887-6924, 8 p.Article

Wilms' tumour gene 1 (WT1) in human neoplasiaKEILHOLZ, U; MENSSEN, H. D; GAIGER, A et al.Leukemia. 2005, Vol 19, Num 8, pp 1318-1323, issn 0887-6924, 6 p.Article

CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual diseaseDWORZAK, M. N; FRÖSCHL, G; PRINTZ, D et al.Leukemia. 2004, Vol 18, Num 4, pp 703-708, issn 0887-6924, 6 p.Article

HPV16-associated tumours: Therapy of surgical minimal residual disease with dendritic cell-based vaccinesREINIS, Milan; INDROVA, Marie; MENDOZA, Luis et al.International journal of oncology. 2004, Vol 25, Num 4, pp 1165-1170, issn 1019-6439, 6 p.Article

Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry to define leukemia-associated immunophenotypes and determine their frequencies in normal bone marrowKERN, Wolfgang; DANHAUSER-RIEDL, Susanne; RATEI, Richard et al.Haematologica (Roma). 2003, Vol 88, Num 6, pp 646-653, issn 0390-6078, 8 p.Article

Clinical significance of residual disease during treatment in childhood acute myeloid leukaemiaCOUSTAN-SMITH, Elaine; RIBEIRO, Raul C; DOWNING, James R et al.British journal of haematology. 2003, Vol 123, Num 2, pp 243-252, issn 0007-1048, 10 p.Article

Minimal residual disease monitoring by flow cytometryVIDRIALES, Maria B; SAN-MIGUEL, Jesus F; ORFAO, Alberto et al.Baillière's best practice & research. Clinical haematology. 2003, Vol 16, Num 4, pp 599-612, issn 1521-6926, 14 p.Article

Monitoring of minimal residual disease in leukemia, advantages and pitfallsCAZZANIGA, Giovanni; GAIPA, Giuseppe; ROSSI, Vincenzo et al.Annals of medicine (Helsinki). 2006, Vol 38, Num 7, pp 512-521, issn 0785-3890, 10 p.Article

Minimal residual disease in neuroblastoma: To GAGE or not to GAGEOLTRA, S; MARTINEZ, F; ORELLANA, C et al.Oncology research. 2004, Vol 14, Num 6, pp 291-295, issn 0965-0407, 5 p.Article

High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome. CommentaryDE WITTE, T; FELLER, N; SCHUURHUIS, G. J et al.Leukemia. 2003, Vol 17, Num 1, pp 39-40, issn 0887-6924, 10 p.Article